Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (DE:IUI1)
XETRA:IUI1
IUI1 Stock Chart & Stats
€400.95
€9.00(1.73%)
At close: 4:00 PM EST
€400.95
€9.00(1.73%)
Day’s Range― - ―
52-Week Range€341.55 - €594.40
Previous CloseN/A
Volume235.00
Average Volume (3M)442.00
Market Cap
$141.15B
Enterprise ValueN/A
Total Cash (Recent Filing)$5.33B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)59.5
Beta0.67
Next Earnings
Jan 22, 2026EPS Estimate
1.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.07
Shares Outstanding358,476,500
10 Day Avg. Volume634
30 Day Avg. Volume442
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)11.28
Price to Sales (P/S)22.20
P/FCF Ratio142.20
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$519.59Price Target Upside29.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
Bulls Say, Bears Say
Bulls Say
Market GrowthThe total available market (TAM) for procedures has expanded significantly from 1.8 million in 2009 to 8 million today, indicating a substantial growth potential for ISRG.
Product LaunchQ3 is the first quarter of broad launch for dV5 in the U.S., and Intuitive just got approval for dV5 in Japan and Europe, all of which should drive upside to placement numbers.
Strategic FocusISRG has identified Cardio as the next key growth area, highlighted by recent hires and job postings for Cardiovascular Sales Manager roles, suggesting a focus on expanding in this market.
Bears Say
Market PenetrationDecelerating greenfield placements could be a function of a more penetrated market or a difficult capex environment, potentially weighing on systems and procedures.
Reimbursement AlignmentESD reimbursement does not align well with the desired payback rate for robotic surgeries.
Technology ChallengesHeavy lift required on Force Feedback. Like many experienced surgeons we've met, our KOL has grown very accustomed to using visual cues to estimate the amount of force applied to tissue. She finds Force Feedback is too restrictive / disruptive.
Intuitive Surgical News
IUI1 FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was €341.55 and its highest was €594.40 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $141.15B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Jan 22, 2026 which is in 92 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Oct 21, 2025. The company reported €2.067 earnings per share for the quarter, beating the consensus estimate of €1.718 by €0.349.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 1.92.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 358,476,500 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of €2.067 in its last earnings report, beating expectations of €1.718. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in DE:IUI1
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$519.59 (29.59% Upside)
$519.59 (29.59% Upside)
Blogger Sentiment
Bullish
DE:IUI1 Sentiment 75%
Sector Average 69%
Sector Average 69%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.02%
12-Months-Change
Fundamentals
Return on Equity
16.02%
Trailing 12-Months
Asset Growth
21.10%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
IUI1 Company Deck
IUI1 Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong growth in revenue, procedures, and technological advancements with successful international expansion and positive clinical outcomes. However, challenges persist in the Chinese market and domestic bariatric procedures decline, with some concerns over net placements.View all DE:IUI1 earnings summariesIUI1 Revenue Breakdown
66.92% U.S.
33.08% Outside of U.S
IUI1 Stock 12 Month Forecast
Average Price Target
€519.59
▲(29.59% Upside)
Technical Analysis
Options Prices
Currently, No data available
---